Related content

Triplenegative breast cancer frequency and type of BRCA mutation: Clues from Sardinia

By                  

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 948-952

Spandidos Publications

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

By Bayraktar Soley  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 145-153

Springer Publishing Company

Access to resources Recommend Favorite

Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer

By                  

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1287-1289

Spandidos Publications

Access to resources Recommend Favorite

Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients

By Plakhins Grigorijs   Irmejs Arvids   Gardovskis Andris   Subatniece Signe   Liepniece-Karele Inta   Purkalne Gunta   Teibe Uldis   Trofimovics Genadijs   Miklasevics Edvins   Gardovskis Janis  

Familial Cancer, Vol. 12, Iss. 4, 2013-12 ,pp. : 683-689

Springer Publishing Company

Access to resources Recommend Favorite